Business UpdateOct 22, 2026, 05:26 PM
NeOnc Technologies Reports Early Clinical Improvement, Signs Abu Dhabi MoU
AI Summary
NeOnc Technologies Holdings, Inc. announced significant developments including early clinical improvement in a young patient treated with its investigational intranasal NEO100 under a Compassionate Care program in Abu Dhabi. The company also signed a Memorandum of Understanding with the Department of Health – Abu Dhabi to advance research and clinical capabilities in oncology and CNS therapeutics. Additionally, NeOnc will be featured on the television series 'Health Uncensored with Dr. Drew' to discuss its non-invasive therapeutic delivery methods for brain tumors.
Key Highlights
- NeOnc Technologies announced early clinical improvement in the first patient treated with investigational intranasal NEO100 in Abu Dhabi.
- The patient, a three-year-old boy with an aggressive brain tumor, is reportedly breathing independently and showing renewed movement.
- NeOnc signed a Memorandum of Understanding (MoU) with the Department of Health – Abu Dhabi to cooperate on oncology and CNS therapeutics research.
- The company will be featured on 'Health Uncensored with Dr. Drew' discussing non-invasive approaches to delivering investigational therapies to brain tumors.
Price Impact
More from NTHI